Med Tech Market Reports
MedTech Business intelligence
supplied through Piribo and GlobalData
Latest reports
Picture archiving and communication systems (PACS) — global
opportunity assessment, competitive landscape and market forecasts to
2016
The report provides market landscape, competitive
landscape and market trends information the Picture Archiving and
Communication Systems (PACS) market. It provides comprehensive
information on the key trends affecting the market, and key analytical
content on the market dynamics. The report also reviews the competitive
landscape and technology offerings. Key geographies covered include the
US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India,
Australia, and Brazil. July 2010
Allergic Rhinitis — Pipeline Assessment and Market Forecasts to
2017
The report is an essential source of information
and analysis on the global allergic rhinitis market. The report
identifies the key trends shaping and driving the global allergic
rhinitis market. The report also provides insight on the prevalent
competitive landscape and the emerging players expected to significantly
shift the market positioning of the existing market leaders. Most
importantly, the report provides valuable insights on the pipeline
products within the global allergic rhinitis sector. July 2010
Hemophilia — Pipeline Assessment and Market Forecasts to 2017
The report is an essential source of information and analysis on the
global hemophilia market. The report identifies the key trends shaping
and driving the global hemophilia market. The report also provides
insights on the prevalent competitive landscape and the emerging players
expected to significantly alter the market positioning of the current
market leaders. July 2010
Europe Futures
Europe Futures will save you time and money in finding
healthcare contracts in Europe. It is a short-track to which countries
are coming into focus with their spending, which have new European
money, which hospitals are “thinking” about new projects and
procurements.
Report:
Global orthopedic devices pipeline landscape: analysis of key upcoming
products and technologies
Key data, information and
analysis on the key orthopedic pipeline devices expected to hit the
market in the next seven years. The report provides information on the
market potential, market scope and expected market penetration of these
products. It also identifies and reviews the existing competing
technologies and the likely impact of the launch on the competitive
landscape. May 2010
Practical Guide to Finding Partners in Pharma and Biotech 3rd
edition
The report takes the reader through the
practical steps required to prepare for partnering, prepare supporting
materials, identify and shortlist potential partners and opportunities,
identifying and contacting the right person in the partner company, and
managing of discussions through to deal negotiation.
Molecular
Diagnostics
This report describes and evaluates the
molecular diagnostics technologies that will play an important role in
practice of medicine, public health, pharmaceutical industry, forensics
and biological warfare in the 21st century. This includes several
polymerase chain reaction (PCR)-based technologies, fluorescent in situ
hybridization (FISH), peptide nucleic acids (PNA), electrochemical
detection of DNA, biochips, nanotechnology and proteomic technologies.
April 2010
The Worldwide Market for Cancer Diagnostics. 4th Edition
This report authored by Kalorama Diagnostic Analyst Shara Rosen,
contains detailed market data on the following IVD segments for their
use in cancer diagnostics: Histology/Cytology, Immunoassays, Flow
Cytometry, Rapid Tests, Molecular Assays, Tissue Arrays, Circulating
Tumor Cells, Pharmacodiagnostics. 2010
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics
The report provides comprehensive understanding and unprecedented access
to the merger and acquisition (M&A) agreements entered into by the
worlds leading biopharma companies from 2003 to end 2009.
Deals and alliances — January
2010
Life science companies' deals and alliances research,
intelligence and forecasts — reports for over 200 companies.
The latest biotechnology
industry reports — January 2010
DNA sequencing, nanobiotechnology, proteomics, RNAi, regenerative
medicine etc
Europe Nuclear Imaging Equipment.
Market Analysis and Opportunity Assessment
The report provides market landscape, competitive landscape and
market trends information on market categories: gamma camera, single
photon emission computed tomography, and positron emission tomography.
More information and Buy online ...
Contrast Media: A Market Snapshot
Contrast agents, also known as contrast media, are used during medical
imaging examinations to highlight specific parts of the body and enhance
their contrast. The study looks at the global contrast media market,
both in terms of revenue and geographic segmentation, during 2008-2015.
More information
and Buy online ...
Medical Equipment Monthly Deals Analysis — January 2010
The report provides detailed information on M&A, Equity/Debt Offerings,
Private Equity, Venture Financing and Partnership transactions
registered in the medical equipment industry in December 2009. Jan 2010
Bristol-Myers Squibb Co.: PharmaVitae Profile
This analysis examines the historical and forecast performance for BMS
in the prescription pharmaceutical sector. The profile encompasses
global company strategy, portfolio and pipeline analysis and assessment
of financial performance, with 1-6 year sales forecasts for key drugs.
Sept 2009
AstraZeneca plc: PharmaVitae Profile
This analysis examines the historical and forecast performance for
AstraZeneca in the Rx pharmaceutical sector. The profile encompasses
global company strategy, portfolio and pipeline analysis and assessment
of financial performance, with 1-6 year sales forecasts for key drugs.
Sept 2009
Abbott Laboratories: PharmaVitae Profile
This analysis examines the historical and forecast performance for
Abbott in the prescription pharmaceutical sector. The profile
encompasses global company strategy, portfolio and pipeline analysis and
assessment of financial performance, with 1-6 year sales forecasts for
key drugs. Sept 2009
The Top 40 Manufacturers Of Diagnostic Imaging Equipment In
Europe
The companies profiled in this report are located across Europe from the
United Kingdom and France to Hungary and Poland. They manufacture the
whole spectrum of imaging equipment including: Analog & Digital X-ray
Systems, Mobile X-ray Units, Mobile C-Arms, Dental X-ray Devices,
Fluoroscopic Imaging Systems, Analog & Digital Mammography Systems,
Mobile Mammography Units, Ultrasound Scanners & Transducers, MRI
Systems, CT Scanners And Nuclear Medicine Imaging Devices.
more ...
Europe Remote Patient Monitoring Market
The report identifies the key trends shaping and driving the dynamism in
the Europe remote patient monitoring market. The report also provides
insight on the prevalent competitive landscape and on the emerging
players which are expected to bring significant shift in the market
standing of the existing leaders. The report also provides valuable
insight on the pipeline products within the Europe remote patient
monitoring market. August 2009
more ...
Medical Equipment Industry Deals Analysis — September 2009
An essential source of data and trend analysis on the mergers and
acquisitions and financings in the medical equipment market. The report
provides detailed information on M&A, Equity/Debt Offerings, Private
Equity, Venture Financing and Partnership transactions registered in the
medical equipment industry in August 2009. The report portrays detailed
comparative data on the number of deals and their value in the last six
months subdivided by deal types, segments, and geographies.
Additionally, the report provides information on top financial advisory
firms in the medical equipment industry. Sept 2009
more ...
Germany Diagnostic Imaging Market Analysis and Forecasts to 2015
GlobalData's report provides market landscape, competitive landscape and
market trends information on six market categories including Computed
Tomography Systems, Mammography Equipment, MRI Systems, Nuclear Imaging
Equipment, Ultrasound Systems and X-Ray Systems. The report provides
comprehensive information on the key trends affecting these categories,
and key analytical insight on the market dynamics. The report also
reviews the competitive landscape in terms of mergers and acquisitions,
pipeline products and technology offerings. Sept 2009
more ...
UK Diagnostic Imaging Market Analysis and Forecasts to 2015
This report by GlobalData provides market landscape,
provides competitive landscape and market trends information on six market
categories including Computed Tomography Systems, Mammography Equipment,
MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-Ray
Systems. The report provides comprehensive information on the key trends
affecting these categories, and key analytical insight on the market
dynamics. The report also reviews the competitive landscape in terms of
mergers and acquisitions, pipeline products and technology offerings.
more ...
In Vitro Diagnostics in a Recession
It is commonly asserted that in vitro diagnostics is a recession-proof
industry. This report tests that assumption: What impact is the downturn
having on in vitro diagnostic companies? What are the best areas of IVD
and the best world markets? How should companies price and market their
products? What are key companies in the market doing at this time?
more ...
Top Ten Global In-Vitro Diagnostics Companies
The global in-vitro diagnostics (IVD) market is forecast to grow at a
rate of 6% to reach $50.0bn in 2012. Roche is the largest player in the
market with a share of 20%. It is followed by Siemens and Abbott, who
both hold 12% of the market. The IVD market is highly consolidated, with
the top ten players holding close to 80% market share. A number of large
in-vivo players have entered the IVD market recently, signalling the
convergence of the two diagnostic fields. Siemens Healthcare is a
prominent example of this trend, following their acquisition of DPC,
Bayer Diagnostics and Dade Behring.
more ...
Top 10 Biotech Companies. Market Outlook, 2008-2023
The global biotech drug market was worth over $75bn in 2007, with
double-figure growth noticeably higher that that of the overall
pharmaceutical market. This report will help you to understand those
developments and their significance. That report provides valuable
commercial information on this exciting industry that no healthcare
company should ignore.
read more ...
Bioinformatics
Markets: Strategies, Business Models and Trends for the Future
This study is arranged to provide an overview of bioinformatics market
segments and offer evidence that these segments are poised for
significant future growth. Each segment is accompanied by analysis and
forecasts by product type and application. March 2009.
read more ...
British
National Formulary
Medicines prescribed in the UK, with special reference to their uses,
cautions, contra-indications, side-effects, doses and relative costs.
read more ...
Personalized Medicine. Scientific & Commercial Aspects
The aim of personalized medicine or individualized treatment is to
match the right drug to the right patient and, in some cases, even to
design the appropriate treatment for a patient according to his/her
genotype. This report describes the latest concepts of development of
personalized medicine based on pharmacogenomics,
pharmacogenetics, pharmacoproteomics, and metabolomics.
Biochip/microarray technologies are also important and bioinformatics is
needed to analyze the immense amount of data generated by various
technologies. more ...
Diabetes Drug
Pipeline. Competitor Analysis
The Competitive Intelligence Report Diabetes Drug Pipeline as of
November 2008 provides a competitor analysis in the development pipeline
of novel antidiabetic treatment modalities for type 1 and 2 diabetes.
The report includes an overview of the major marketed diabetes drugs and
the respective markets sizes and describes the corporate diabetes drug
product portfolios and R&D pipelines of more than 160 companies
worldwide. November 2008
Biopharmaceutical Expression Systems and Genetic Engineering
Technologies. Current and Future Manufacturing Platforms
In currently marketed products there has been little basic change in the
technologies used for commercial-scale manufacture of biopharmaceutical
products. New expression systems and recent improvements available for current
systems have the potential to revolutionize the biopharmaceutical industry! Lower
costs and efficiencies of newer expression systems are driving these
changes. This book provides manufacturers with the information they need
to make the shift to increased productivity. November 2008
Why do drugs fail?
This report analyses recent drug failure events and examines
potential areas of remedy for regulators and companies. Greedy companies
being economical with the truth?
Overzealous regulators pursuing political agendas? Poorly designed or
inconclusive clinical trials? What action can the industry and
regulators take to improve their performance in this critical area?
November 2008
Global Surgical Equipment Investment Opportunities, Analysis and
Forecasts to 2012
This report is an essential source for key information and data
relating to the Global surgical equipment market. The report provides
overview of key trends, drivers and restraints, future outlook, pipeline
products, news, financial deals and competitive landscape and key
developments in the Global surgical equipment devices market. It also
offers global and country level, detailed and comprehensive coverage of
market revenue, volume, distribution and company share information.
October 2008
Global Patient Monitoring Investment Opportunities, Analysis and
Forecasts to 2012
This report is an essential source for key information and data
relating to the Global patient monitoring devices market. The report
provides overview of key trends, drivers and restraints, future outlook,
pipeline products, news, financial deals and competitive landscape and
key developments in the Global patient monitoring devices market. It
also offers global and country level, detailed and comprehensive
coverage of market revenue, volume, distribution and company share
information. October 2008
Western Europe, Healthcare Sector Pulse, April-June 2008
This Health Industry Insights update describes the Western
European healthcare sector environment (payers and providers) in the
second quarter of 2008 and discusses the macroeconomic and
healthcare sector-specific trends. The main section looks at the
major ICT contracts signed over the same period and other
initiatives in place. Includes the NHS-Fujitsu case.
September 2008
Nanobiotechnologies applications, markets and companies
The report starts with an introduction to various techniques and
materials that are relevant to nanobiotechnology. It includes some of
the physical forms of energy such as nanolasers. Some of the
technologies are scaling down such as microfluidics to nanofluidic
biochips and others are constructions from bottom up. Application in
life sciences research, particularly at the cell level sets the stage
for role of nanobiotechnology in healthcare in subsequent chapters.
October 2008.
Read more ...
Nanotechnology. Revolutionizing R&D to Develop Smarter Therapeutics and
Diagnostics
Nanotechnologies have already attracted over $3bn of global government
funding as part of efforts to enhance a range of disciplines including
pharmaceuticals, drug delivery and healthcare monitoring. Advances in
nanomaterials, nanostructures and nanosystems are expected to drive the
value of the global nanotehnology market to over a trillion dollars by
2015, but many companies are remaining cautious, preferring to monitor
developments in academia prior to making substantial investments.
read more ...
Biomarkers: The Future of Next-Generation Drug R&D
This report analyzes the hot global market for biomarkers and related
assays or tests used in drug R&D. The study reviews this dynamic market
by looking at drug research and development spending trends, M&As,
alliances, major diseases, applications, tools, technologies, products
and services. This report suggests the future direction of the market
for biomarkers and related '-omic' or pharmacogenomic (PGx) assays or
tests used in the next-generation of drug R&D. This study sizes the
world market and growth rate of biomarkers and assays for drug R&D
spending to 2012. October 2008
Read more ...
RNA interference
markets
Since its discovery, the naturally occurring RNA (ribonucleic acid)
interference effect has been acclaimed as the most exciting technical
breakthrough in biological research in the last decade. Some industry
analysts predict that RNA interference (RNAi) may even surpass PCR as a
top technology. Read more
...
Medical Nanotechnology Markets
Nanotechnology has reached critical mass. Nowhere is this more evident
than in medicine. Rising medical costs, demands for less-invasive
procedures and pressures for immediate feedback of medical conditions,
all point to nanotechnology as offering a new approach in healthcare.
According to US National Science Foundation estimates, by 2015 the
annual global market for nano-related goods and services will top $1
trillion, thus making it one of the fastest-growing industries in
history. Read more
...
Molecular Diagnostics.
Technologies, Markets and Companies
This best-selling report describes and evaluates the molecular
diagnostics technologies that will play an important role in practice of
medicine, public health, pharmaceutical industry, forensics and
biological warfare in the 21st century. Aimed at chief executives and
chief development officers, it is the most comprehensive and up-to-date
one-stop source of information on technical and commercial aspects of
molecular diagnostics. It includes profiles of 250 companies
more ...
Point of Care
Diagnostic Testing. World Markets
The report describes the specific market segment of the in vitro
diagnostics market called point-of-care testing (POCT). It examines
these clinical measurement devices and their reagents and supplies as
utilized in near-patient environments like hospitals, clinics and
doctor's offices. The study defines the dollar volume of sales, both
worldwide and in the US, and analyzes the factors that influence the
size and the growth of the market segments.
more ... September
2008
Top 20
cancer therapy brands
Cancer therapy brand sales totaled over $30 billion in the seven major
markets in 2007, growing by 20.1% since 2006. The high growth of this
market makes it attractive to companies keen to emulate the blockbuster
status achieved by several brands. However, with several impending
patent expiries due, companies will need to work hard to maximize their
return throughout the lifecycle of their brands. September 2008.
Read more ...
Antidiabetics — Switching to new antidiabetics drives market growth
Datamonitor expects the antidiabetics market in the seven major markets is expected to
grow from $18 billion in 2007 to $29 billion in 2017 at a rate of 5%
CAGR. Significant unmet needs remain in diabetes fuelling a large
pipeline. The epidemiological growth of the market, driven by the
obesity epidemic and improved diagnosis rates, is further driving the
market. September 2008.
Read more ...
Health Care Equipment & Supplies in Germany
Publication Date: July 2008
Publisher: Datamonitor
Pages: 35
Price £180.00 approximately: $361 | €226
Health Care Equipment & Supplies in France
Publication Date: July 2008
Publisher: Datamonitor
Pages: 31
Price £180.00 approximately: $361 | €226
Health
Care Equipment & Supplies in the United Kingdom
Publication Date: July 2008
Publisher: Datamonitor
Pages: 33
Price: £180.00 approximately: $361 | €226
McKesson Corporation Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo)...
IBA
Health Limited Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo) ...
TOSHIBA Medical Systems Corporation Medical Equipment Company Share
Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information
(goes to Piribo) ...
Smiths Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo) ...
Philips Medical Systems Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information
(goes to Piribo) ...
France Diabetes Care Devices Investment Opportunities Analysis and Forecasts to 2012
Publication date: June 2008
Publisher Global Markets Direct
Price £1,515.00 approximately: $3,000 | €1,926
More information ...
Canada Diabetes Care Devices Investment Opportunities, Analysis and
Forecasts to 2012
Publication date: June 2008
Publisher: Global Markets Direct
Price £1,515.00 approximately: $3,000 | €1,926
More information (goes to Piribo)...
Canada Orthopedic Devices Investment Opportunities, Analysis and
Forecasts to 2012
Publication date: June 2008
Publisher: Global Markets Direct
Price £1,515.00 approximately: $3,000 | €1,926
More information (goes to Piribo) ...
France Cardiovascular Devices Investment Opportunities, Analysis and
Forecasts to 2012
Publication date: June 2008
Publisher: Global Markets Direct
Pages: 612
Price £1,515.00 approximately: $3,000 | €1,926
More information (goes to Piribo) ...
Companion
Diagnostics Market
A Realistic Assessment of the Opportunities, Challenges, Key Players and
Important Trends in Personalized Medicine
Publication date: June 2008
Publisher: Kalorama Information
GE
Healthcare Product Pipeline Analysis
Publication date: May 2008
Publisher: Global Markets Direct
Germany Healthcare IT Investment Opportunities, Analysis and Forecasts
to 2012
Publication date: May 2008
Publisher: Global Markets Direct
United States Medical Equipment Markets
Investment Opportunities, Analysis and Forecasts in Medical Devices to
2012
Publication date: May 2008
Publisher: Global Markets Direct
Cell Therapy. Technologies, Markets and Companies
Publication Date: May 2008
Publisher: Jain PharmaBiotech
Major World Markets for Stents and The Economics of Drug-Eluting
Technology
Publication date: May 2008
Publisher: Kalorama Information
Surgical Robot Market Shares, Market Strategies, and Market
Forecasts, 2008-2014
Publication Date: January 2008
Publisher: Wintergreen Research
The European
Hospital Register (CD-ROM)
Publication Date: March 2008
Publisher: Walnut Medical
See the broad categories:
- Biotechnology
- Diagnostics
- Diseases
- Healthcare
- Information Technology
- Medical devices
- Medical technology companies
- Pharmacy
- Telehealth